Craft

Elixiron Immunotherapeutics

Total Funding

$37.5 M

Elixiron Immunotherapeutics Summary

Company Summary

Overview
Elixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases. It applies translational medicine and clinical findings to advance potential therapy for Alzheimer's disease and improve cancer immunotherapy and treatment of Vitiligo.
Type
Private
Status
Active
Founded
2017
HQ
TW | view all locations
Website
https://www.elixiron.com/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

2 locations detected

  • Taipei City HQ

    Taiwan

  • Shanghai Shi

    China

    building, 5th floor, 4560 Jinke Rd, Pudong Xinqu

Footer menu